ebselen has been researched along with pterostilbene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billack, B; Pietka-Ottlik, M; Pino, MA | 1 |
| Billack, B; Lulla, A; Młochowski, J; Piętka-Ottlik, M; Pino, MA; Sparavalo, O | 1 |
2 other study(ies) available for ebselen and pterostilbene
| Article | Year |
|---|---|
Ebselen analogues reduce 2-chloroethyl ethyl sulphide toxicity in A-431 cells.
Topics: Antioxidants; Azoles; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chemical Warfare Agents; Humans; Isoindoles; Mustard Gas; Organoselenium Compounds; Oxidative Stress; Protective Agents; Resveratrol; Stilbenes | 2013 |
Ebselen reduces the toxicity of mechlorethamine in A-431 cells via inhibition of apoptosis.
Topics: Antidotes; Antioxidants; Apoptosis; Ascorbic Acid; Azoles; Caspase 3; Caspase 9; Cell Line; Chemical Warfare Agents; Cytoprotection; Humans; Irritants; Isoindoles; Mechlorethamine; Organoselenium Compounds; Resveratrol; Stilbenes | 2013 |